Evotec AG engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through two segments: the EVT Execute and EVT Innovate segments. The EVT Executive segment includes drug discovery solutions. The EVT Innovate segment involves advanced drug candidates and early-stage internal discovery programs. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.